Correlation Between Chinook Therapeutics and Mineralys Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Chinook Therapeutics and Mineralys Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Chinook Therapeutics and Mineralys Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Chinook Therapeutics and Mineralys Therapeutics, Common, you can compare the effects of market volatilities on Chinook Therapeutics and Mineralys Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Chinook Therapeutics with a short position of Mineralys Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Chinook Therapeutics and Mineralys Therapeutics,.
Diversification Opportunities for Chinook Therapeutics and Mineralys Therapeutics,
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Chinook and Mineralys is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Chinook Therapeutics and Mineralys Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mineralys Therapeutics, and Chinook Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Chinook Therapeutics are associated (or correlated) with Mineralys Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mineralys Therapeutics, has no effect on the direction of Chinook Therapeutics i.e., Chinook Therapeutics and Mineralys Therapeutics, go up and down completely randomly.
Pair Corralation between Chinook Therapeutics and Mineralys Therapeutics,
If you would invest 868.00 in Mineralys Therapeutics, Common on November 9, 2024 and sell it today you would earn a total of 137.00 from holding Mineralys Therapeutics, Common or generate 15.78% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 0.0% |
| Values | Daily Returns |
Chinook Therapeutics vs. Mineralys Therapeutics, Common
Performance |
| Timeline |
| Chinook Therapeutics |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
| Mineralys Therapeutics, |
Chinook Therapeutics and Mineralys Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Chinook Therapeutics and Mineralys Therapeutics,
The main advantage of trading using opposite Chinook Therapeutics and Mineralys Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Chinook Therapeutics position performs unexpectedly, Mineralys Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mineralys Therapeutics, will offset losses from the drop in Mineralys Therapeutics,'s long position.| Chinook Therapeutics vs. Pliant Therapeutics | Chinook Therapeutics vs. Crinetics Pharmaceuticals | Chinook Therapeutics vs. Ascendis Pharma AS | Chinook Therapeutics vs. Ventyx Biosciences |
| Mineralys Therapeutics, vs. Krystal Biotech | Mineralys Therapeutics, vs. Immunovant | Mineralys Therapeutics, vs. Foghorn Therapeutics | Mineralys Therapeutics, vs. Shattuck Labs |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |